CD96
Basic information
Region (hg38): 3:111292719-111665996
Links
Phenotypes
GenCC
Source:
- C syndrome (Limited), mode of inheritance: AD
- C syndrome (Limited), mode of inheritance: AR
- C syndrome (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
C syndrome | AD | Cardiovascular | Individuals have been described with congenital heart anomalies, and awareness may enable early diagnosis and management | Cardiovascular; Craniofacial; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic | 7258228; 3981579; 2260586; 10405439; 16835930; 16528754; 17847009 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD96 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 14 | 18 | ||||
missense | 40 | 48 | ||||
nonsense | 1 | |||||
start loss | 1 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 2 | 2 | 1 | 5 | ||
non coding | 25 | 33 | ||||
Total | 0 | 0 | 71 | 25 | 10 |
Variants in CD96
This is a list of pathogenic ClinVar variants found in the CD96 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-111542250-T-C | Uncertain significance (Oct 17, 2023) | |||
3-111542260-A-T | C syndrome | Pathogenic (-) | ||
3-111542294-A-G | Uncertain significance (Dec 05, 2022) | |||
3-111542298-A-AT | C syndrome | Conflicting classifications of pathogenicity (Apr 25, 2023) | ||
3-111542326-T-C | Benign (Jan 12, 2024) | |||
3-111545070-C-G | not specified | Uncertain significance (May 05, 2023) | ||
3-111545079-A-G | not specified | Uncertain significance (Mar 30, 2024) | ||
3-111545115-C-T | Likely benign (Apr 24, 2023) | |||
3-111545161-C-A | Likely benign (Aug 04, 2023) | |||
3-111545161-C-T | Likely benign (Oct 17, 2018) | |||
3-111545165-G-A | Uncertain significance (Nov 28, 2023) | |||
3-111545183-C-A | not specified | Uncertain significance (Nov 13, 2023) | ||
3-111545262-A-T | Uncertain significance (Dec 07, 2023) | |||
3-111545313-G-A | Benign (Jun 01, 2022) | |||
3-111545333-G-C | not specified | Uncertain significance (Aug 08, 2023) | ||
3-111545343-T-C | Uncertain significance (May 17, 2021) | |||
3-111545361-G-A | CD96-related disorder • not specified | Uncertain significance (Oct 25, 2023) | ||
3-111545395-GAC-AAT | Uncertain significance (Sep 16, 2018) | |||
3-111545409-A-G | CD96-related disorder | Likely benign (Apr 29, 2019) | ||
3-111567526-C-A | not specified | Uncertain significance (Nov 09, 2021) | ||
3-111567526-C-G | Uncertain significance (Oct 25, 2021) | |||
3-111567528-G-C | CD96-related disorder | Benign (Jan 29, 2024) | ||
3-111567553-C-A | not specified | Uncertain significance (Apr 23, 2024) | ||
3-111567553-C-T | Likely benign (Nov 19, 2022) | |||
3-111567556-T-C | not specified | Uncertain significance (Nov 29, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CD96 | protein_coding | protein_coding | ENST00000283285 | 15 | 373032 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.39e-11 | 0.781 | 125225 | 6 | 516 | 125747 | 0.00208 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.467 | 329 | 306 | 1.08 | 0.0000149 | 3837 |
Missense in Polyphen | 76 | 70.09 | 1.0843 | 930 | ||
Synonymous | -1.21 | 126 | 110 | 1.15 | 0.00000581 | 1105 |
Loss of Function | 1.69 | 22 | 32.4 | 0.679 | 0.00000157 | 393 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0185 | 0.0183 |
Ashkenazi Jewish | 0.000993 | 0.000993 |
East Asian | 0.00642 | 0.00644 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.000308 | 0.000308 |
Middle Eastern | 0.00642 | 0.00644 |
South Asian | 0.000425 | 0.000425 |
Other | 0.00114 | 0.00114 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in adhesive interactions of activated T and NK cells during the late phase of the immune response. Promotes NK cell-target adhesion by interacting with PVR present on target cells. May function at a time after T and NK cells have penetrated the endothelium using integrins and selectins, when they are actively engaging diseased cells and moving within areas of inflammation.;
- Disease
- DISEASE: C syndrome (CSYN) [MIM:211750]: A syndrome characterized by trigonocephaly, severe mental retardation, hypotonia, variable cardiac defects, redundant skin, and dysmorphic facial features, including upslanted palpebral fissures, epicanthal folds, depressed nasal bridge, and low-set, posteriorly rotated ears. {ECO:0000269|PubMed:17847009}. Note=The disease is caused by mutations affecting the gene represented in this entry. A chromosomal aberration involving CD96 has been found in a patient with C syndrome. Translocation t(3;18)(q13.13;q12.1). CD96 gene was located at the 3q13.13 breakpoint. Precise structural analysis around the breakpoint showed that the gene was disrupted by the translocation in exon 5, probably leading to premature termination or loss of expression of CD96 protein. No gene was detected at the chromosome 18 breakpoint.;
- Pathway
- Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Adaptive Immune System
(Consensus)
Recessive Scores
- pRec
- 0.0762
Intolerance Scores
- loftool
- 0.980
- rvis_EVS
- -0.6
- rvis_percentile_EVS
- 18.19
Haploinsufficiency Scores
- pHI
- 0.198
- hipred
- N
- hipred_score
- 0.169
- ghis
- 0.455
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0357
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cd96
- Phenotype
Gene ontology
- Biological process
- cytokine production involved in inflammatory response;negative regulation of natural killer cell cytokine production;immune response;cell adhesion;cell-matrix adhesion;response to lipopolysaccharide;negative regulation of interferon-gamma production;regulation of immune response
- Cellular component
- cytoplasm;plasma membrane;integral component of plasma membrane;adherens junction
- Molecular function